Technology
Reading cancer's molecular signals in blood and urine.
A focused panel of microRNA markers, measured on standard laboratory equipment and combined by machine learning into one clear result.
How a Mirnow test works
- 01
Sample
A standard blood draw (or urine sample for future tests) is collected at the clinic and processed in our laboratory using standardised protocols.
At the clinic - 02
Measurement
A focused panel of markers is quantified by RT-qPCR, a proven and widely available technology.
In our lab - 03
AI interpretation
A proprietary machine-learning model combines the marker signals into a single result.
Machine learning - 04
Report
The referring doctor receives a clear report to support the next clinical decision.
To the doctor
What makes it different
Focused panel, not a broad screen
A small number of carefully selected markers keeps the test robust and affordable.
Proprietary assay design
Primers and analysis are developed in-house.
Rigorous normalisation
Our team built gQuant, an open-source tool for choosing reliable reference genes in studies.
Runs on standard equipment
No specialised sequencing platform required, which supports wider access.
Protected innovation
Patent application filed on process and methods.
See the evidence behind the science.
Our tests rest on peer-reviewed research and a prospective multicentre study now under way.